St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) approval of the next-generation Merlin.Net Patient Care Network (PCN), an Internet-based central repository for patient device data gathered at the time of implant procedures, at in-clinic follow-up visits or from patient-initiated remote follow-up appointments. The next-generation Merlin.net PCN Version 3.
Lawyer Central Also Recommends These Stories: